Nexus Surgical and Medicare Inc Stock Price Today (NSE: NEXUSSURGL)
Fundamental Score
Nexus Surgical and Medicare Inc Share Price Live NSE/BSE & Institutional Fundamental Analysis
Nexus Surgical and Medicare Inc share price today is ₹17.12, up +0.00% on NSE/BSE as of 17 February 2026. Nexus Surgical and Medicare Inc (NEXUSSURGL) is a Small-cap company in the Other Financial Services sector with a market capitalisation of ₹8.61 (Cr). The 52-week high for NEXUSSURGL share price is ₹N/A and the 52-week low is ₹N/A. At a P/E ratio of 16.55x, NEXUSSURGL is currently trading below its industry average P/E of 30.94x. The company has a Return on Equity (ROE) of 61.73% and a debt-to-equity ratio of 0.00.
Nexus Surgical and Medicare Inc Share Price Chart — NSE/BSE Historical Performance
Returns & Performance
ROE
ROCE
OPM (5Y)
Div Yield
Nexus Surgical and Medicare Inc Valuation Check
P/E Ratio
Industry P/E
Market Cap
Growth Engine
Profit Growth (Q)
Sales Growth (Q)
Sales Growth (5Y)
EPS Growth (5Y)
Profit Growth (5Y)
Balance Sheet Health
Debt to Equity
Int. Coverage
Free Cash Flow (5Y)
Shareholding
Promoter
FII
DII
Pledged
Institutional Deep-Dive
Bull Run Research Hub
Nexus Surgical and Medicare Inc Share Price: A Financial Analysis
The Other Financial Services sector is currently experiencing a period of increased regulatory scrutiny, impacting investor sentiment and requiring firms to demonstrate robust compliance frameworks. This analysis delves into the financial standing of Nexus Surgical and Medicare Inc, with a particular focus on its current valuation and profitability. Currently, the Nexus Surgical and Medicare Inc share price sits at ₹17.5, with a Price-to-Earnings (PE) ratio of 16.55. This initial data point provides a starting ground for a more detailed examination of the company's underlying fundamentals.
One of the most striking aspects of Nexus Surgical and Medicare Inc's financial profile is its exceptionally high Return on Capital Employed (ROCE) of 83.95%. This significantly surpasses the sector average and indicates a highly efficient allocation of capital. Such a high ROCE creates a strong economic moat, suggesting the company possesses a competitive advantage that allows it to generate substantial profits from its invested capital. A higher ROCE enables the business to reinvest profits into growth, strengthening its competitive position further.
In comparison to its peers, it is important to consider qualitative factors. While
Sumedha Fiscal Services Ltd might be strong on revenue growth, Nexus Surgical and Medicare Inc's management team appears to be prioritizing high-return projects as evidenced by the ROCE, suggesting a different strategic approach. A comparison of management commentary in the companies' annual reports and earnings calls will provide more depth to this observation. A further deep dive into operational efficiency may reveal why Nexus Surgical and Medicare's revenue per employee may be better than peers.The current PE ratio of 16.55 for Nexus Surgical and Medicare Inc share price requires further investigation. While this figure provides a relative valuation benchmark, it should be assessed in conjunction with projected growth rates and risk factors. Is the market fairly assessing the company's growth potential, given its high ROCE? Detailed analysis is necessary to understand the relative value proposition. This analysis forms a part of an 80-parameter fundamental audit conducted under the verification of Sweta Mishra. *This analysis is purely observational and does not constitute investment advice.*
Labels (e.g., "Excellent", "Good") are peer-based vs industry/sector averages — data-only, not advice
Nexus Surgical and Medicare Inc Fundamental Analysis & Valuation Benchmarking
Educational evaluation of NEXUSSURGL across key market metrics for learning purposes.
Positive Indicators
9 factors identified
Strong Return on Equity (61.73%)
Observation: Efficient use of shareholders' capital generating superior returns.
Analysis: ROE >15% indicates strong profitability and effective management. This metric suggests the company can generate substantial returns on invested capital.
Excellent ROCE Performance (83.95%)
Observation: Superior returns on capital employed across business operations.
Analysis: ROCE >15% demonstrates efficient capital deployment and strong operational performance.
Attractive Valuation (P/E: 16.55 vs Industry: 30.94)
Observation: Trading at discount to industry peers.
Analysis: P/E below industry average may present value opportunity.
Strong Revenue Growth (18.18%)
Observation: Healthy sales growth indicates market demand and execution capability.
Analysis: Revenue growth >15% suggests strong market position and growth potential.
Consistent Growth Track Record (27.02% CAGR)
Observation: Strong 5-year sales compound annual growth rate.
Analysis: Consistent sales CAGR >12% demonstrates sustainable growth model.
Excellent EPS Growth (75.54% CAGR)
Observation: Outstanding 5-year earnings per share compound growth.
Analysis: EPS CAGR >15% indicates strong wealth creation potential.
Strong Profit Growth Track Record (75.54% CAGR)
Observation: Consistent 5-year profit compound annual growth rate.
Analysis: Profit CAGR >15% demonstrates scalable business model.
Debt-Free Balance Sheet (D/E: 0.00)
Observation: Low leverage provides financial flexibility and reduced risk.
Analysis: Conservative debt structure offers resilience during economic downturns.
Zero Share Pledging Risk
Observation: No promoter shares pledged as collateral.
Analysis: Absence of share pledging eliminates potential forced-selling pressure.
Risk Factors
3 factors identified
Profit Decline Concern (-19.05%)
Observation: Significant year-over-year profit contraction observed.
Analysis: Declining profitability requires investigation into underlying causes.
Low Promoter Commitment (18.73%)
Observation: Reduced promoter stake may indicate limited confidence.
Analysis: Low promoter holding may raise questions about management commitment.
No Dividend Distribution
Observation: Company does not currently pay dividends to shareholders.
Analysis: Zero dividend yield may indicate growth reinvestment focus or cash flow constraints.
Nexus Surgical and Medicare Inc Financial Statements
Comprehensive financial data for Nexus Surgical and Medicare Inc including income statement, balance sheet and cash flow
About NEXUSSURGL (Nexus Surgical and Medicare Inc)
Nexus Surgical and Medicare Inc (NEXUSSURGL) is listed on the National Stock Exchange (NSE) and Bombay Stock Exchange (BSE) of India. The company operates in the Other Financial Services sector with a current market capitalisation of ₹8.61 (Cr). Nexus Surgical and Medicare Inc has delivered a Return on Equity (ROE) of 61.73% and a ROCE of 83.95%. The debt-to-equity ratio stands at 0.00, reflecting the company's capital structure. Investors tracking NEXUSSURGL share price can monitor key metrics including P/E ratio, promoter holding of 18.73%, and quarterly earnings growth.
Company Details
Key Leadership
NEXUSSURGL Share Price: Frequently Asked Questions
What is the current share price of Nexus Surgical and Medicare Inc (NEXUSSURGL)?
As of 17 Feb 2026, 10:17 am IST, Nexus Surgical and Medicare Inc share price is ₹17.12. The NEXUSSURGL stock has a market capitalisation of ₹8.61 (Cr) on NSE/BSE.
Is NEXUSSURGL share price Overvalued or Undervalued?
NEXUSSURGL share price is currently trading at a P/E ratio of 16.55x, compared to the industry average of 30.94x. Based on this relative valuation, the Nexus Surgical and Medicare Inc stock appears to be Undervalued against its sector peers.
What is the 52-week high and low of NEXUSSURGL share price?
The 52-week high of NEXUSSURGL share price is ₹N/A and the 52-week low is ₹N/A.
What factors affect the Nexus Surgical and Medicare Inc share price?
Key factors influencing NEXUSSURGL share price include quarterly earnings growth (Sales Growth: 18.18%), raw material costs, government infrastructure spending, and institutional flows (FII/DII holding).
Is Nexus Surgical and Medicare Inc a good stock for long-term investment?
Nexus Surgical and Medicare Inc shows a 5-year Profit Growth of 75.54% and an ROE of 61.73%. Long-term investors should consider these fundamentals alongside the debt-to-equity ratio of 0.00 before investing in NEXUSSURGL shares.
How does Nexus Surgical and Medicare Inc compare with its industry peers?
Nexus Surgical and Medicare Inc competes with major peers in the Other Financial Services. Investors should compare NEXUSSURGL share price P/E of 16.55x and ROE of 61.73% against the industry averages to determine competitive standing.
What is the P/E ratio of NEXUSSURGL and what does it mean?
NEXUSSURGL share price has a P/E ratio of 16.55x compared to the industry average of 30.94x. Investors pay ₹17 for every ₹1 of annual earnings.
How is NEXUSSURGL performing according to Bull Run's analysis?
NEXUSSURGL has a Bull Run fundamental score of 53.7/100, indicating moderate strength with some areas for improvement. This comprehensive rating is based on 15+ financial parameters.
What sector and industry does NEXUSSURGL belong to?
NEXUSSURGL operates in the Other Financial Services industry. This classification helps understand the competitive landscape and sector-specific trends affecting Nexus Surgical and Medicare Inc share price.
What is Return on Equity (ROE) and why is it important for NEXUSSURGL?
NEXUSSURGL has an ROE of 61.73%, which indicates excellent management efficiency. ROE measures how efficiently Nexus Surgical and Medicare Inc generates profits from shareholders capital.
How is NEXUSSURGL debt-to-equity ratio and what does it indicate?
NEXUSSURGL has a debt-to-equity ratio of 0.00, which indicates conservative financing with low financial risk.
What is NEXUSSURGL dividend yield and is it a good dividend stock?
NEXUSSURGL offers a dividend yield of 0.00%, meaning you receive ₹0.00 annual dividend for every ₹100 invested in Nexus Surgical and Medicare Inc shares.
How has NEXUSSURGL share price grown over the past 5 years?
NEXUSSURGL has achieved 5-year growth rates of: Sales Growth 27.02%, Profit Growth 75.54%, and EPS Growth 75.54%.
What is the promoter holding in NEXUSSURGL and why does it matter?
Promoters hold 18.73% of NEXUSSURGL shares, with 0.00% pledged. High promoter holding often indicates strong management confidence in Nexus Surgical and Medicare Inc.
What is NEXUSSURGL market capitalisation category?
NEXUSSURGL has a market capitalisation of ₹9 crores, placing it in the Small-cap category.
How volatile is NEXUSSURGL stock?
NEXUSSURGL has a beta of N/A. A beta > 1 suggests the Nexus Surgical and Medicare Inc stock is more volatile than the market, while a beta < 1 suggests it is less volatile.
What is NEXUSSURGL operating profit margin trend?
NEXUSSURGL has a 5-year average Operating Profit Margin (OPM) of 10.01%, indicating the company's operational efficiency.
How is NEXUSSURGL quarterly performance?
Recent quarterly performance shows Nexus Surgical and Medicare Inc YoY Sales Growth of 18.18% and YoY Profit Growth of -19.05%.
What is the institutional holding pattern in NEXUSSURGL?
NEXUSSURGL has FII holding of 0.00% and DII holding of 0.00%. Significant institutional holding often suggests professional confidence in the Nexus Surgical and Medicare Inc stock.